Femme et Homme
- | Pays :
- Denmark
- | Organes : -
- | Spécialités : -
Extrait
This trial is conducted in Europe. The aim of this trial is to test if there is bioequivalence between the insulin aspart 100 U/mL (U100) formulation and the new insulin aspart 200 U/mL (U200) formulation.
Critère d'inclusion
- diabetes ,Healthy